MOLECULAR MODELLING, 3D-QSAR, AND DRUG DOCKING STUDIES ON THE ROLE OF NATURAL ANTICOAGULANT COMPOUNDS IN ANTITHROMBOTIC THERAPY.

Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines. Int J Mol Sci (2016) 0.77

3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS. Int J Pharm Sci Res (2016) 0.75

Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol (2013) 3.08

Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50

PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population. J Thromb Haemost (2012) 1.69

Sepsis, thrombosis and organ dysfunction. Thromb Res (2011) 1.47

Factor XIII deficiency. Haemophilia (2008) 1.26

A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies. Eur J Med Chem (2010) 0.89

Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study. J Stroke Cerebrovasc Dis (2011) 0.88

Risk factors and incidence of deep vein thrombosis in lower extremities among critically ill patients. J Clin Nurs (2012) 0.88

Predictors of cerebral venous thrombosis and arterial ischemic stroke in young Asian women. J Stroke Cerebrovasc Dis (2011) 0.87

Dual anticoagulant/antiplatelet persulfated small molecules. Eur J Med Chem (2011) 0.85

Comparison of Composer and ORCHESTRAR. Proteins (2008) 0.85

Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost (2011) 0.83

Partial least square and k-nearest neighbor algorithms for improved 3D quantitative spectral data-activity relationship consensus modeling of acute toxicity. Environ Toxicol Chem (2014) 0.81

Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. Blood (1996) 0.81

Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke. Int J Lab Hematol (2012) 0.80

Factor XIII and venous thromboembolism. Semin Thromb Hemost (2011) 0.80

Acquired factor XIII deficiency: a therapeutic challenge. Thromb Haemost (2013) 0.80

Deep vein thrombosis caused by heparin-induced thrombocytopenia thrombosis. Intern Med (2013) 0.79

Measurement of factor XIII activity in plasma. Clin Chem Lab Med (2012) 0.79

In too deep: understanding, detecting and managing DVT. Br J Nurs (2010) 0.78